Form 4 for CORT CORCEPT THERAPEUTICS INC
Accepted 2024-08-02 00:00:00 ET · period of report 2024-07-31 · accession 0000950170-24-090052 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-02 | 2024-07-31 | CORT | BELANOFF JOSEPH K | CEO, Dir | F - Tax | $38.67 | -259.6K | 539.2K | -32% | -$10.04M |
| D | 2024-08-02 | 2024-07-31 | CORT | BELANOFF JOSEPH K | CEO, Dir | M - OptEx | $3.29 | +450.0K | 798.8K | +129% | +$1.48M |
| D | 2024-08-02 | 2024-07-31 | CORT | BELANOFF JOSEPH K | CEO, Dir | M - OptEx | $0.00 | -450.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-31 | F | D | 259,583 | $38.67 | 539,228 | D | — | — | |
| 2 | Common | Common Stock | 2024-07-31 | M | A | 450,000 | $3.29 | 798,811 | D | — | — | |
| 3 | Derivative | Stock option (right to buy) | 2024-07-31 | M | D | 450,000 | $0.00 | 0 | D | $3.29 · — to 2025-02-18 | 450,000 Common Stock | (F3) Fully exercisable. |